Avivagen Terminates Exclusive U.S. Sales and Distribution Agreement

• Agreement with CSA Animal Nutrition to be terminated effective immediately • Avivagen to explore new sales and distributions opportunities to capitalize on significant market opportunity in the United States Ottawa, ON / Business Wire/ May 7, 2021 / –/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products […]

Avivagen Continues Market Growth with New Customer Win in Western Mexico

•  Order signifies important growth in key production territories in Mexico Ottawa, ON / Business Wire/ May 6, 2021 / –Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health […]

Avivagen Announces Largest Single Customer Purchase Order

•Largest purchase amount and longest duration purchase to-date •Four tonne per month order secured •Order follows five successful OxC-betaTM Livestock commercial trials conducted with various species over the past six months Ottawa, ON / Business Wire/ May 3, 2021 / Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products […]